Enovis Corp Reports Q3 2026 Growth Driven by Reconstructive Segment
Enovis Corp (ENOV) reported third-quarter results featuring a 5% organic revenue growth, reaching net sales of $559 million. The performance was primarily driven by the Reconstructive segment, which saw 6% organic growth across extremities and joint replacements. Despite geopolitical headwinds in Western Europe and the Middle East, the company achieved an adjusted EPS of $0.88, a 17% increase year-over-year. Operational efficiency contributed to an adjusted EBITDA margin expansion of 120 basis points to 18.5%. The company also demonstrated improved liquidity with $35 million in free cash flow for the quarter and announced a new $200 million share repurchase program. Looking ahead, Enovis raised its full-year adjusted EBITDA and EPS guidance while narrowing its revenue outlook.
Tickers: $ENOV
Topics: Adjusted EPS Free Cash Flow Full-Year Guidance Net Sales Organic Revenue Growth